Anbio Biotechnology (NNNN)Healthcare | Medical Instruments & Supplies | Frankfurt am Main, Germany | NasdaqGM
7.67 USD
-0.11
(-1.414%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 7.55 -0.12 (-0.120%) ⇩ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:50 a.m. EDT
The immediate outlook is sharply bearish as the stock has collapsed from $10.15 to $6.81 in just two weeks, trading well below its $11.43 fifty-day average and $23.14 two-hundred-day average. This severe technical breakdown suggests strong selling pressure and a lack of near-term support, warranting a low short-term rating. Despite the price crash, the underlying business shows signs of life with robust gross margins (87%) and operating margins (59%), alongside a massive 74% revenue surge. However, these fundamentals are currently priced out of reality, reflected in a P/S ratio of 34.6x and a P/E of 48.6x, which creates a disconnect between the company's operational success and its market valuation. The price history is too brief to assess a multi-year trend, so the long-term view remains neutral pending further confirmation of sustainability. Finally, there is no dividend income to consider. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.917358 |
| AutoETS | 0.920585 |
| AutoARIMA | 0.921678 |
| AutoTheta | 0.972886 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 3.54 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.056 |
| Excess Kurtosis | 0.18 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.198 |
| Market Cap | 336,645,504 |
| Trailing P/E | 54.79 |
| Profit Margins | 74.06% |
| Website | https://www.anbiobiotechnology.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.82957286 |
| Address1 | Friedrich-Ebert-Anlage 35-37 |
| All Time High | 55.65 |
| All Time Low | 5.18 |
| Ask | 9.89 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 272,740 |
| Average Daily Volume3 Month | 82,338 |
| Average Volume | 82,338 |
| Average Volume10Days | 272,740 |
| Bid | 11.55 |
| Bid Size | 1 |
| Book Value | 0.687 |
| City | Frankfurt am Main |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | Germany |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.67 |
| Current Ratio | 344.311 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 7.915 |
| Day Low | 7.35 |
| Earnings Timestamp End | 1,745,837,940 |
| Earnings Timestamp Start | 1,745,837,940 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 37.556 |
| Enterprise Value | 324,744,288 |
| Eps Trailing Twelve Months | 0.14 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 10.7542 |
| Fifty Day Average Change | -3.0842 |
| Fifty Day Average Change Percent | -0.28679028 |
| Fifty Two Week Change Percent | -82.95728 |
| Fifty Two Week High | 51.33 |
| Fifty Two Week High Change | -43.660004 |
| Fifty Two Week High Change Percent | -0.85057473 |
| Fifty Two Week Low | 6.61 |
| Fifty Two Week Low Change | 1.06 |
| Fifty Two Week Low Change Percent | 0.16036308 |
| Fifty Two Week Range | 6.61 - 51.33 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,739,975,400,000 |
| Float Shares | 39,691,251 |
| Free Cashflow | -9,605,703 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 27 |
| Fullday Change | -0.11 |
| Fullday Change Percent | -1.41388 |
| Fullday Price | 7.55 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.87236 |
| Gross Profits | 7,543,162 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.047849998 |
| Held Percent Institutions | 0.04948 |
| Implied Shares Outstanding | 43,891,200 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ipo Expected Date | 2,025-02-19 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany. |
| Long Name | Anbio Biotechnology |
| Market | us_market |
| Market Cap | 336,645,504 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1914568067 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 6,403,463 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 341,473,536 |
| Open | 7.78 |
| Operating Cashflow | -6,739,075 |
| Operating Margins | 0.59093 |
| Payout Ratio | 0.0 |
| Phone | 49 698 7003 9170 |
| Post Market Change | -0.119999886 |
| Post Market Change Percent | -1.5645356 |
| Post Market Price | 7.55 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 7.78 |
| Price Hint | 2 |
| Price To Book | 11.164484 |
| Price To Sales Trailing12 Months | 38.93276 |
| Profit Margins | 0.74055 |
| Quick Ratio | 177.127 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.11000013 |
| Regular Market Change Percent | -1.4138834 |
| Regular Market Day High | 7.915 |
| Regular Market Day Low | 7.35 |
| Regular Market Day Range | 7.35 - 7.915 |
| Regular Market Open | 7.78 |
| Regular Market Previous Close | 7.78 |
| Regular Market Price | 7.67 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 251,617 |
| Return On Assets | 0.14664 |
| Return On Equity | 0.27049 |
| Revenue Growth | 0.739 |
| Revenue Per Share | 0.198 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 43,891,200 |
| Shares Percent Shares Out | 0.00059999997 |
| Shares Short | 26,210 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 31,583 |
| Short Name | Anbio Biotechnology |
| Short Percent Of Float | 0.00059999997 |
| Short Ratio | 0.62 |
| Source Interval | 15 |
| Symbol | NNNN |
| Total Cash | 11,901,231 |
| Total Cash Per Share | 0.271 |
| Total Debt | 0 |
| Total Revenue | 8,646,844 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.14 |
| Trailing P E | 54.785713 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 22.948574 |
| Two Hundred Day Average Change | -15.278574 |
| Two Hundred Day Average Change Percent | -0.66577446 |
| Type Disp | Equity |
| Volume | 251,617 |
| Website | https://www.anbiobiotechnology.com |
| Zip | 60,327 |